about
Renal replacement therapy in acute kidney injury: controversy and consensusIndications and management of mechanical fluid removal in critical illness.Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKIVenous congestion: are we adding insult to kidney injury in sepsis?Perioperative blood transfusion is associated with a gene transcription profile characteristic of immunosuppression: a prospective cohort studyIncidence and associations of acute kidney injury after major abdominal surgery.Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality.Clinical review: Optimal dose of continuous renal replacement therapy in acute kidney injuryCombination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass.Oliguria as predictive biomarker of acute kidney injury in critically ill patients.Urine hepcidin has additive value in ruling out cardiopulmonary bypass-associated acute kidney injury: an observational cohort study.Subclinical cardiopulmonary dysfunction in stage 3 chronic kidney diseaseContinuous renal replacement therapy: recent advances and future research.Infection in the critically ill--questions we should be asking.Renal blood flow, fractional excretion of sodium and acute kidney injury: time for a new paradigm?Fluid management for the prevention and attenuation of acute kidney injury.Fluid Overload.Renal recovery after acute kidney injuryPostoperative goal-directed therapy and development of acute kidney injury following major elective noncardiac surgery: post-hoc analysis of POM-O randomized controlled trial.The intensive care medicine agenda on acute kidney injury.Superiority of Serum Cystatin C Over Creatinine in Prediction of Long-Term Prognosis at Discharge From ICU.Acute kidney injury and mortality 1 year after major non-cardiac surgery.Preoperative renal dysfunction and mortality after non-cardiac surgery.Changes in gene expression following trauma are related to the age of transfused packed red blood cells.Low avidity recognition of self-antigen by T cells permits escape from central tolerance.In-hospital clinical outcomes after upper gastrointestinal surgery: Data from an international observational study.Automated Fluid Management for Treatment of Rhabdomyolysis.Recent trials in critical care nephrology.Association between gene expression biomarkers of immunosuppression and blood transfusion in severely injured polytrauma patients.Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass.Acute kidney injury after cardiac surgery: the injury that keeps on hurting?*.Have biomarkers failed in acute kidney injury? We are not sure.Incidence, risk factors and outcome associations of intra-abdominal hypertension in critically ill patients.Acute kidney injury: Creatinine and AKI--through a glass, darkly.Low preoperative hepcidin concentration as a risk factor for mortality after cardiac surgery: a pilot study.Association between gene expression biomarkers of immunosuppression and blood transfusion in severely injured polytrauma patients.Bioimpedance as a measure of fluid overload in patients recently admitted to intensive care.Acute kidney injury of all severity is associated with extended hospitalization after critical illness.Perioperative Plasma-Lyte use reduces the incidence of renal replacement therapy and hyperkalaemia following renal transplantation when compared with 0.9% saline: a retrospective cohort study.Does early-start renal replacement therapy improve outcomes for patients with acute kidney injury?
P50
Q26998864-650C98B9-9A04-4864-9DDE-A0F81215EBE2Q30459016-56BB8CCC-93BA-4839-824D-113D8B51A7CDQ33715849-0E7849BD-64FE-468D-8C21-CA5FF0E2F757Q33749850-4F8F20B8-776B-4934-81B8-17459F4CEBB1Q34364446-4B381EEE-C5EF-4688-A06B-AD9BA1EF5F7EQ34502917-3A5DF5EF-E797-4AED-ABDF-8464226C2F43Q35559502-9B660E2D-DD52-483A-8E5C-2374896F8400Q35559644-69BA8E27-3978-4CAA-8163-5D5318FD7D05Q35981992-9A0033AD-FAA0-4EC9-A563-3E46E228DBCFQ36070429-BFD3E6FE-F5B3-40F4-8920-3268A6D7955BQ36070477-30A8CAAD-7E41-46F5-8ABD-B5962C764607Q36841969-A50C6EF5-143F-4830-9050-EA38C9505920Q37774244-8EF478BC-2EB6-4142-B449-A459FDB9F3B4Q37852469-F69BB71F-25DF-43E2-84E3-A26A69075016Q38041302-EB410F27-2E4A-4CC5-A7CB-F63192277772Q38161780-33990DD8-396D-4C25-8FC2-C6CDC9C7DFE5Q38593662-95FE0A09-1401-4D2E-9833-B4C7269E7D40Q38688295-9909F2AB-15F3-44A0-81DA-FF384638474EQ38725072-A337785F-FBDB-4DB7-B3D3-331ED8321842Q39110696-DAEF6715-2964-4E98-ACE7-867DDAF83342Q40160349-90250058-E036-437D-849F-700E79824BF0Q40327410-5E6402D4-9787-4442-9EF0-E063DB4DA21CQ40681035-57F452DA-3B14-4EA9-BA23-97E6F7B678DAQ41467118-A10351FF-3E2B-46B1-AF2E-4C00AC3B5B91Q41671634-5BDE0900-2CDD-46A1-9C7A-06C469702162Q41997542-42F9E189-3B04-45E2-8032-020EC623930DQ42356649-51732651-31EB-45A4-B4AC-BC7238198559Q43081428-27E03985-64FD-48C8-885B-07959EB9C49EQ44165321-8939BA2C-A00C-425D-9787-DE9BCA387EFEQ44412373-931083DD-AB80-40ED-B498-8FB9D7E76A30Q44584459-D33D0461-96F9-4BD6-A4DD-8F2F2E6D3AFEQ45057705-5BDD8545-E9A3-4D69-AC29-CBFA4CED7F54Q45121923-0F89AEB6-130C-4444-9EFE-33FCEA49AE72Q45894780-8B7FDBFC-335F-43DC-9FC2-85D136E29F94Q45895705-77E6F7B4-662F-4E8C-A112-8A1A4E9D594EQ46015086-90326E12-E1EE-4797-845E-67C680C56123Q46056658-B87D3E4E-21EE-400C-AC42-C3AAD8E9316DQ46588545-251FC56B-6761-462A-88F1-5242E6CF6D61Q47097292-23A340EA-72DE-48A1-B45A-80B2EA683ECFQ48939918-FD7BC4F5-11F6-4F57-A47A-2623283CFBED
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
John Prowle
@ast
John Prowle
@en
John Prowle
@es
John Prowle
@nl
John Prowle
@sl
type
label
John Prowle
@ast
John Prowle
@en
John Prowle
@es
John Prowle
@nl
John Prowle
@sl
prefLabel
John Prowle
@ast
John Prowle
@en
John Prowle
@es
John Prowle
@nl
John Prowle
@sl
P1053
D-5014-2009
P106
P1153
6504359389
P21
P31
P3829
P496
0000-0002-5002-2721